As used throughout this Quarterly Report on Form 10-Q, unless the context otherwise indicates, the terms "we," "us," "our," "Tivity Health," or the "Company" refer collectively to Tivity Health, Inc. and its wholly-owned subsidiaries. Please read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes included under Item 1. "Financial Statements" of this report.





COVID-19


In January 2020, the Secretary of the U.S. Department of Health and Human Services declared a national public health emergency due to a novel strain of coronavirus, which causes the disease known as "COVID-19." In March 2020, the World Health Organization characterized the outbreak of COVID-19 as a global pandemic. By March 31, 2020, substantially all of the fitness centers in our national network were temporarily closed, which had an adverse impact on our results of operations for the first quarter of 2020 and beyond because a significant portion of revenues from our SilverSneakers program is based on member visits to a fitness partner location. Some locations began reopening in May 2020 and additional locations reopened in June and throughout the remainder of 2020. As of March 31, 2021, a significant majority of our fitness partner locations were open. SilverSneakers in-person visits totaled 11.2 million for the first quarter of 2021, compared to 25.3 million and 9.3 million for the first and fourth quarters of 2020, respectively. In addition, while the number of active subscribers for Prime Fitness declined from April through December 2020, it increased slightly during the first quarter of 2021 and we expect it to stabilize for the rest of 2021.

As fitness locations closed as a result of the pandemic, we quickly adapted to the changing needs of our members and clients by launching a new and dynamic suite of virtual offerings, which we will continue to offer. Virtual visits grew significantly, from 12,000 for the first quarter of 2020 to 1.2 million for the first quarter of 2021. We believe these digital offerings not only allow our currently homebound members to stay active and connected with the help of SilverSneakers but that they will also be a critical contributor to our new digitally-enabled member engagement platform going forward.





Overview


Tivity Health, Inc. was founded and incorporated in Delaware in 1981. Through our four programs, SilverSneakers, Prime Fitness, WholeHealth Living, and Wisely WellTM, we are focused on becoming the modern destination for healthy living, especially for seniors and older adults.

We offer SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans. We also offer Prime Fitness, a fitness facility access program, through commercial health plans, employers, and other sponsoring organizations. Our national network of fitness centers delivers both SilverSneakers and Prime Fitness. Our fitness networks encompass approximately 16,000 partner locations and nearly 1,000 alternative locations that provide classes outside of traditional fitness centers. We also offer virtual fitness experiences, including live instructor-led classes. Through our WholeHealth Living program, which we sell primarily to health plans, we offer a continuum of services related to complementary, alternative, and physical medicine. Our WholeHealth Living network includes relationships with over 17,000 complementary, alternative, and physical medicine practitioner locations to serve individuals through health plans and employers who seek health services such as chiropractic care, acupuncture, physical therapy, occupational therapy, massage therapy, and more. Finally, through our Wisely Well brand, we offer meals designed to support individuals and caregivers who are seeking meal convenience as well as those recovering after a hospitalization or living with chronic conditions.

Effective as of December 9, 2020, we completed the sale of Nutrisystem to Kainos pursuant to terms of the Purchase Agreement. At the closing (the "Closing") of the transactions contemplated by the Purchase Agreement, Nutrisystem, Inc. and its subsidiaries were acquired by, and became wholly owned subsidiaries of, Kainos. Pursuant to the terms of the Purchase Agreement, Kainos paid to the Company an aggregate purchase price, after giving effect to customary indebtedness and cash adjustments, of approximately $559 million, which amount is subject to a customary working capital adjustment post-Closing. We used the significant majority of the net proceeds from the divestiture to pay down $519 million of principal on the term loans under our Credit



                                       23

--------------------------------------------------------------------------------

Agreement. Results of operations for Nutrisystem have been classified as discontinued operations for all periods presented in the consolidated financial statements.

Forward-Looking Statements

This report contains forward-looking statements, which are based upon current expectations, involve a number of risks and uncertainties, and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical statements of fact and those regarding the intent, belief, or expectations of the Company, including, without limitation, all statements regarding the Company's future earnings, revenues, and results of operations. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary from those in the forward-looking statements as a result of various factors, including, but not limited to:





   •  impacts from the COVID-19 pandemic (including the response of governmental
      authorities to combat and contain the pandemic, the closure of fitness
      centers in our national network (or operational restrictions imposed on such
      fitness centers), reclosures, and potential additional reclosures as a
      result of surges in positive COVID-19 cases) on our business, operations or
      liquidity;




   •  the risks associated with changes in macroeconomic conditions (including the
      impacts of any recession or changes in consumer spending resulting from the
      COVID-19 pandemic), widespread epidemics, pandemics (such as the current
      COVID-19 pandemic) or other outbreaks of disease, geopolitical turmoil, and
      the continuing threat of domestic or international terrorism;




   •  our ability to collect accounts receivable from our customers and amounts
      due under our sublease agreements;




  • the market's acceptance of our new products and services;




   •  our ability to develop and implement effective strategies and to anticipate
      and respond to strategic changes, opportunities, and emerging trends in our
      industry and/or business, as well as to accurately forecast the related
      impact on our revenues and earnings;




   •  the impact of any impairment of our goodwill, intangible assets, or other
      long-term assets;




   •  our ability to attract, hire, or retain key personnel or other qualified
      employees and to control labor costs;




   •  the effectiveness of the reorganization of our business and our ability to
      realize the anticipated benefits;




   •  our ability to effectively compete against other entities, whose financial,
      research, staff, and marketing resources may exceed our resources;




   •  the impact of legal proceedings involving us and/or our subsidiaries,
      products, or services, including any claims related to intellectual property
      rights, as well as our ability to maintain insurance coverage with respect
      to such legal proceedings and claims on terms that would be favorable to us;




   •  the impact of severe or adverse weather conditions, the current COVID-19
      pandemic, and the potential emergence of additional health pandemics or
      infectious disease outbreaks on member participation in our programs;




   •  the risks associated with deriving a significant concentration of our
      revenues from a limited number of our customers, many of whom are health
      plans;




   •  our ability and/or the ability of our customers to enroll participants and
      to accurately forecast their level of enrollment and participation in our
      programs in a manner and within the timeframe we anticipate;




                                       24

--------------------------------------------------------------------------------






   •  our ability to sign, renew and/or maintain contracts with our customers
      and/or our fitness partner locations under existing terms or to restructure
      these contracts on terms that would not have a material negative impact on
      our results of operations;




   •  the ability of our health plan customers to maintain the number of covered
      lives enrolled in those health plans during the terms of our agreements;




   •  our ability to add and/or retain active subscribers in our Prime Fitness
      program;




   •  the impact of any changes in tax rates, enactment of new tax laws, revisions
      of tax regulations, or any claims or litigation with taxing authorities;




   •  the impact of a reduction in Medicare Advantage health plan reimbursement
      rates or changes in plan design;




   •  the impact of any new or proposed legislation, regulations and
      interpretations relating to Medicare, Medicare Advantage, Medicare
      Supplement and privacy and security laws;




  • the impact of healthcare reform on our business;




   •  the risks associated with potential failures of our information systems or
      those of our third-party vendors, including as a result of telecommuting
      issues associated with personnel working remotely, which may include a
      failure to execute on policies and processes in a work-from-home or remote
      model;




   •  the risks associated with data privacy or security breaches, computer
      hacking, network penetration and other illegal intrusions of our information
      systems or those of third-party vendors or other service providers,
      including those risks that result from the increase in personnel working
      remotely, which may result in unauthorized access by third parties, loss,
      misappropriation, disclosure or corruption of customer, employee or our
      information, or other data subject to privacy laws and may lead to a
      disruption in our business, costs to modify, enhance, or remediate our
      cybersecurity measures, enforcement actions, fines or litigation against us,
      or damage to our business reputation;




   •  the risks associated with changes to traditional office-centered business
      processes and/or conducting operations out of the office in a work-from-home
      or remote model by us or our third-party vendors during adverse situations
      (e.g., during a crisis, disaster, or pandemic), which may result in
      additional costs and/or may negatively impact productivity and cause other
      disruptions to our business;




  • our ability to enforce our intellectual property rights;




   •  the risk that our indebtedness may limit our ability to adapt to changes in
      the economy or market conditions, expose us to interest rate risk for the
      variable rate indebtedness and require a substantial portion of cash flows
      from operations to be dedicated to the payment of indebtedness;




   •  our ability to service our debt, make principal and interest payments as
      those payments become due, and remain in compliance with our debt covenants;




   •  our ability to obtain adequate financing to provide the capital that may be
      necessary to support our current or future operations;




  • counterparty risk associated with our interest rate swap agreements; and


   •  other risks detailed in this report and our other filings with the
      Securities and Exchange Commission.

We undertake no obligation to update or revise any such forward-looking statements.





                                       25

--------------------------------------------------------------------------------






Business Strategy


Our strategy is to become the modern destination for healthy living. We will expand beyond fitness by establishing an engagement platform that enables personalized member interaction with all of our offerings, and we will partner with other payors and service providers to aggregate services to members under the SilverSneakers umbrella. We plan to accelerate growth in our core SilverSneakers and Prime Fitness businesses by expanding and strengthening our fitness partner network, continuing to grow and scale our new virtual offerings, and expanding our popular community-based offerings. The continued development of our suite of digital offerings will enable a more tailored, interactive, and impactful experience across a variety of areas, including fitness, social connection, community involvement, volunteering, and enrichment. In addition, we plan to accelerate growth in our WholeHealth Living offering through market share expansion and improved technology.





Critical Accounting Policies


We describe our significant accounting policies in Note 1 to the consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 ("2020 Form 10-K"). We prepare the consolidated financial statements in conformity with generally accepted accounting principles in the United States ("U.S. GAAP"), which requires us to make estimates and judgments that affect the reported amounts of assets and liabilities and related disclosures at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.

We believe the following accounting policies are the most critical in understanding the estimates and judgments that are involved in preparing our financial statements and the uncertainties that could impact our results of operations, financial condition, and cash flows.

Revenue Recognition

We account for revenue from contracts with customers in accordance with Accounting Standards Codification ("ASC") Topic 606 "Revenue from Contracts with Customers" ("ASC Topic 606"). The unit of account in ASC Topic 606 is a performance obligation, which is a promise in a contract to transfer to a customer either a distinct good or service (or bundle of goods or services) or a series of distinct goods or services provided over a period of time. ASC Topic 606 requires that a contract's transaction price, which is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, is to be allocated to each performance obligation in the contract based on relative standalone selling prices and recognized as revenue when or as the performance obligation is satisfied.

We earn revenue from continuing operations primarily from three programs: SilverSneakers senior fitness, Prime Fitness and WholeHealth Living. We provide the SilverSneakers senior fitness program to members of Medicare Advantage, Medicare Supplement, and group retiree plans through our contracts with those plans. We offer Prime Fitness, a fitness facility access program, through contracts with commercial health plans, employers, and other sponsoring organizations that allow their members to individually purchase the program. We sell our WholeHealth Living program primarily to health plans.

The significant majority of our customer contracts contain one performance obligation - to stand ready to provide access to our network of fitness locations and fitness programming - which is satisfied over time as services are rendered each month over the contract term. Unsatisfied performance obligations at the end of a particular month primarily relate to certain monthly memberships for our Prime Fitness program, which are recorded as deferred revenue on the consolidated balance sheet and recognized as revenue during the immediately subsequent month. There was no material revenue recognized during the three months ended March 31, 2021 from performance obligations satisfied in a prior period.

Our fees are variable month to month and are generally billed per member per month ("PMPM") or billed based on a combination of PMPM and member visits to a network location. We bill PMPM fees by multiplying the contractually negotiated PMPM rate by the number of members eligible for or receiving our services during the month. We bill for member visits approximately one month in arrears once actual member visits are known. Payments from customers are typically due within 30 days of invoice date. When material, we capitalize costs to obtain contracts with customers and amortize them over the expected recovery period.



                                       26

--------------------------------------------------------------------------------

Our customer contracts include variable consideration, which is allocated to each distinct month over the contract term based on eligible members and/or member visits each month. The allocated consideration corresponds directly with the value to our customers of our services completed for the month. Under the majority of our contracts, we recognize revenue each month using the practical expedient available under ASC 606-10-55-18, which provides that revenue is recognized in the amount for which we have the right to invoice. ASC 606-10-50-14(b) provides an optional exemption, which we have elected to apply, from disclosing remaining performance obligations when revenue is recognized from the satisfaction of the performance obligation in accordance with the "right to invoice" practical expedient.

Although we evaluate our financial performance and make resource allocation decisions based upon the results of our single operating and reportable segment, we believe the following information depicts how our revenues and cash flows are affected by economic factors. For the three months ended March 31, 2021, revenue from our SilverSneakers program, which is predominantly contracted with Medicare Advantage and Medicare Supplement plans, comprised approximately 74% of revenues from continuing operations, while revenue from our Prime Fitness and WholeHealth Living programs comprised approximately 21% and 5%, respectively, of revenues from continuing operations.

Sales and usage-based taxes are excluded from revenues.

Impairment of Intangible Assets and Goodwill

We review goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (during the fourth quarter of our fiscal year) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable. Following the sale of Nutrisystem in December 2020, we have a single reporting unit.

As part of the annual impairment test, we may elect to perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If we elect not to perform a qualitative assessment or we determine that it is more likely than not that the fair value of the reporting unit is less than its carrying value, we perform a quantitative review as described below.

During a quantitative review of goodwill, we estimate the fair value of the reporting unit based on our market capitalization and compare such fair value to the carrying value of the reporting unit. If the fair value of the reporting unit exceeds its carrying amount, no impairment is indicated. If the fair value of the reporting unit is less than its carrying amount, impairment of goodwill is measured as the excess of the carrying amount over fair value.

Except for a tradename that has an indefinite life and is not subject to amortization, we amortize identifiable intangible assets over their estimated useful lives on a straight-line or accelerated basis based on the period for which the economic benefits of the asset are expected to be realized. We assess the potential impairment of intangible assets subject to amortization whenever events or changes in circumstances indicate that the carrying values may not be recoverable. If we determine that the carrying value of other identifiable intangible assets may not be recoverable, we calculate any impairment using an estimate of the asset's fair value based on the estimated price that would be received to sell the asset in an orderly transaction between market participants.

We review indefinite-lived intangible assets for impairment on an annual basis (during the fourth quarter of our fiscal year) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable. We estimate the fair value of our indefinite-lived tradename using the relief-from-royalty method, which requires us to estimate significant assumptions such as the long-term growth rates of future revenues associated with the tradename, the royalty rate for such revenue, the terminal growth rate of revenue, the tax rate, and a discount rate. Changes in these estimates and assumptions could materially affect the estimates of fair value for the tradename.





Key Performance Indicators



In managing our business, we regularly review and analyze a number of key performance indicators ("KPIs"), including revenues, adjusted EBITDA (both in dollars and as a percentage of revenues), and free cash flow.



                                       27

--------------------------------------------------------------------------------

Adjusted EBITDA and free cash flow are not calculated in accordance with U.S. GAAP ("non-GAAP"). These KPIs help us monitor our performance, identify trends affecting our business, determine the allocation of resources, and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business.

Following the divestiture of Nutrisystem, we have only one reportable segment and therefore no longer review and analyze revenues on a segment-level basis or adjusted EBITDA on a segment-level basis as KPIs. Instead, we review and analyze revenues from continuing operations and adjusted EBITDA from continuing operations. We updated our definition of adjusted EBITDA during the first quarter of 2021 to exclude other (income)/expense related to de-designated swaps. We consider such (income)/expense to be outside the performance of our ongoing core business operations and believe that presenting Adjusted EBITDA excluding other (income)/expense provides increased transparency as to the operating costs of our current business performance. We did not revise the prior period's Adjusted EBITDA amounts because there were no costs similar in nature to these items.

Additionally, beginning in the fourth quarter of 2020, we revised the definition of free cash flow such that it is reduced by settlement on derivatives not designated as hedges, a new item for 2020 that did not exist in prior periods. Settlement on derivatives not designated as hedges arose in 2020 due to the de-designation of certain interest rate swaps in the fourth quarter of 2020 in connection with the repayment of a portion of the principal on the term loans under our Credit Agreement, as further described in Note 11 of the notes to consolidated financial statements included in this report. We believe it is appropriate to exclude settlement on derivatives not designated as hedges from free cash flow because these payments are similar to interest payments (which are reflected in cash flow from operating activities) and they reduce our cash available to repay debt or make other investments.





                                                           Three Months Ended
(In $000s)                                                     March 31,
                                                         2021              2020
Revenues from continuing operations                 $      108,085     $     159,692
Adjusted EBITDA from continuing operations                  41,194            30,242
Adjusted EBITDA as a percentage of revenues from
continuing operations                                         38.1 %            18.9 %




   •  Revenues - we review year-over-year changes in revenue from continuing
      operations as a key measure of our success in growing our business. In
      addition to measuring revenue in total, we also measure and report revenue
      by program type or source of revenue, as detailed in Note 4 of the notes to
      the consolidated financial statements included in this report, i.e.,
      SilverSneakers, Prime Fitness, WholeHealth Living, and Other. Evaluating
      revenue by program type or source helps us identify and address changes in
      product mix, broad market factors that may affect our revenues, and
      opportunities for future growth.




   •  Adjusted EBITDA is a non-GAAP measure and is defined by the Company as
      earnings before interest, taxes, depreciation and amortization, acquisition,
      integration, and project costs, CEO transition costs, restructuring charges,
      and other (income)/expense. We believe adjusted EBITDA provides investors a
      helpful measure for comparing our operating performance with our historical
      operating results as well as the performance of other companies that may
      have different financing and capital structures or tax rates. We believe it
      is a useful indicator of the operational strength and performance of our
      business. Because adjusted EBITDA may be defined differently by other
      companies in our industry, the financial measure presented herein may not be
      comparable to similarly titled measures of other companies. A reconciliation
      of adjusted EBITDA to net income (the most comparable U.S. GAAP measure) is
      set forth below.




                                       28

--------------------------------------------------------------------------------






                                                           Year Ended March 31,
(In thousands)                                            2021               2020

Income from continuing operations, GAAP basis $ 19,944 $ 8,275 Income tax expense

                                            7,620              3,136
Interest expense                                             10,756             11,270
Depreciation expense                                          2,683              2,030
EBITDA from continuing operations, non-GAAP basis
(1)                                                  $       41,003      $      24,711
Acquisition, integration, project and CEO
transition costs (2)                                          1,321              5,049
Restructuring charges (3)                                         -                482
Other (income)/expense (4)                                   (1,130 )                -
Adjusted EBITDA from continuing operations,
non-GAAP basis (5)                                   $       41,194      $      30,242




   (1) EBITDA from continuing operations is a non-GAAP financial measure.  We
       believe it is useful to investors to provide disclosures of our operating
       results and guidance on the same basis as that used by management.  You
       should not consider EBITDA from continuing operations in isolation or as a
       substitute for income from continuing operations determined in accordance
       with U.S. GAAP.




   (2) Acquisition, integration, project, and CEO transition costs consist of
       pre-tax charges of $1,321 and $5,049 for the three months ended March 31,
       2021 and 2020, respectively, primarily incurred in connection with the
       acquisition and integration of Nutrisystem and with the termination of our
       former CEO in February 2020 and the hiring of our new CEO in June 2020.




   (3) Restructuring charges consist of pre-tax charges of $482 for the three
       months ended March 31, 2020, primarily related to a restructuring of
       corporate support infrastructure and of executive leadership.




   (4) Other (income)/expense consists of pre-tax income of $1,130 related to
       certain interest rate swap agreements that no longer qualify for hedge
       accounting treatment ("de-designated swaps") and require changes in fair
       value to be recognized each period in current earnings, as further
       described in Note 11 of the notes to consolidated financial statements
       included in this report.




   (5) Adjusted EBITDA from continuing operations is a non-GAAP financial
       measure.  We exclude acquisition, integration, project, and CEO transition
       costs, restructuring charges, and other (income)/expense from this measure
       because of its comparability to our historical operating results.  We
       believe it is useful to investors to provide disclosures of our operating
       results on the same basis as that used by management.  You should not
       consider Adjusted EBITDA from continuing operations in isolation or as a
       substitute for income from continuing operations determined in accordance
       with U.S. GAAP. Additionally, because Adjusted EBITDA from continuing
       operations may be defined differently by other companies in the Company's
       industry, the non-GAAP financial measure presented here may not be
       comparable to similarly titled measures of other companies.




   •  Free cash flow is a non-GAAP measure and is defined by the Company as net
      cash flows provided by operating activities less acquisition of property and
      equipment and settlement on derivatives not designated as hedges.  We
      believe free cash flow is useful to management and investors to measure (i)
      our performance, (ii) the strength of the Company and its ability to
      generate cash, and (iii) the amount of cash that is available to repay debt
      or make other investments. A reconciliation of free cash flow to cash flows
      from operating activities (the most comparable GAAP measure) is set forth
      below.




                                                       Three Months Ended
(In thousands)                                              March 31,
                                                        2021          2020

Net cash flows provided by operating activities $ 22,618 $ 47,023 Acquisition of property and equipment

                    (1,561 )     (4,875 )
Settlement on derivatives not designated as hedges       (1,633 )          -
Free cash flow                                       $   19,424     $ 42,148






                                       29

--------------------------------------------------------------------------------






Outlook


Although there is significant uncertainty relating to the potential impacts of the COVID-19 pandemic on our business going forward, including the duration of the outbreak, the timing and duration of any operational restrictions applicable to our fitness partner locations, the impact on member participation in our SilverSneakers programs, our ability to continue to attract subscribers for our Prime Fitness program, and the ultimate medium- and long-term impact of the pandemic on the global economy, we expect our results from continuing operations for the short term to continue to be adversely impacted by COVID-19.

Executive Overview of Results

The key financial results for the three months ended March 31, 2021 are:





   •  Revenues from continuing operations of $108.1 million compared to $159.7
      million for the three months ended March 31, 2020; and




   •  Pre-tax income from continuing operations of $19.9 million compared to $8.3
      million for the three months ended March 31, 2020. Pre-tax income for the
      three months ended March 31, 2021 includes:


      o  $10.8 million of interest expense compared to $11.3 million for the same
         period in 2020;


      o  $1.3 million of acquisition, integration, project, and CEO transition
         costs compared to $5.0 million for the same period in 2020;


      o  $1.2 million of marketing expenses compared to $7.3 million for the same
         period in 2020; and


      o  $0.0 million of restructuring and related charges compared to $0.5
         million for the same period in 2020.




Results of Operations



The following table sets forth the components of the consolidated statements of operations for the three months ended March 31, 2021 and 2020 expressed as a percentage of revenues from continuing operations.





                                                                Three Months Ended March 31,
                                                                 2021                  2020
Revenues                                                             100.0 %               100.0 %
Cost of revenue (exclusive of depreciation included below)            53.0 %                72.1 %
Marketing expenses                                                     1.1 %                 4.6 %
Selling, general and administrative expenses                           9.0 %                 7.5 %
Depreciation expense                                                   2.5 %                 1.3 %
Restructuring and related charges                                      0.0 %                 0.3 %
Operating income (1)                                                  34.4 %                14.2 %

Interest expense                                                      10.0 %                 7.1 %
Other (income) expense, net                                           (1.0 )%                0.0 %
Total non-operating expense, net (1)                                   8.9 %                 7.1 %
Income before income taxes (1)                                        25.5 %                 7.1 %

Income tax expense                                                     7.1 %                 2.0 %
Income from continuing operations (1)                                 18.5 %                 5.2 %




(1) Figures may not add due to rounding.






Revenues


Revenues from continuing operations were $108.1 million for the three months ended March 31, 2021 compared to $159.7 million for the same period in 2020, a decrease of $51.6 million, primarily as a result of a net decrease in SilverSneakers revenue of $41.8 million driven by a decrease in revenue-generating visits beginning



                                       30

--------------------------------------------------------------------------------

in March 2020 due to the COVID-19 pandemic. As a result, revenues from PMPM fees represented 53% of SilverSneakers revenue for the three months ended March 31, 2021, compared to 36% for the same period in 2020. In addition, revenue from Prime Fitness decreased by $10.2 million due to a decrease in active subscribers for the three months ended March 31, 2021 compared to the same period in 2020.





Cost of Revenue



Cost of revenue from continuing operations (excluding depreciation) as a percentage of revenues decreased from the three months ended March 31, 2020 (72.1%) to the three months ended March 31, 2021 (53.0%), primarily due to a higher mix of revenues from PMPM fees in the first quarter of 2021, as noted above, coupled with a decrease in visit costs due to a decline in participation levels (compared to such levels prior to the COVID-19 pandemic).





Marketing Expenses


Marketing expenses from continuing operations as a percentage of revenues decreased from the three months ended March 31, 2020 (4.6%), to the three months ended March 31, 2021 (1.1%), primarily due to decreased spending in the first quarter of 2021 on SilverSneakers television advertising, due in part to the COVID-19 pandemic as well as a shift in our media mix towards more targeted digital marketing.

Selling, General and Administrative Expenses

Selling, general and administrative expenses from continuing operations as a percentage of revenues increased from the three months ended March 31, 2020 (7.5%) to the three months ended March 31, 2021 (9.0%) primarily due to (i) the fixed nature of certain costs that cannot be reduced proportionately with reductions in revenue, and (ii) an increase in share-based compensation expense due to (a) the timing and design of annual long-term incentive awards, and (b) grants of long-term incentive awards in May 2020 and August 2020 to the Company's Board of Directors, executive officers, and certain other employees, all of whose cash compensation was reduced for a significant portion of 2020 in order to preserve liquidity and manage cash flow in response to the COVID-19 pandemic, with the value of such grants being equal as closely as reasonably possible to the amount of the cash compensation reduction. These increases were partially offset by decreases in (i) transition, acquisition, and integration costs, and (ii) CEO transition-related expenses associated with the termination of our former CEO in February 2020 and the hiring of a new CEO in June 2020.

Restructuring and Related Charges

During the first quarter of 2019, we began a reorganization primarily related to integrating the Nutrisystem business and streamlining our corporate and operations support (the "2019 Restructuring Plan"). The 2019 Restructuring Plan concluded during the first quarter of 2020. For the three months ended March 31, 2020, we incurred restructuring charges from continuing operations of $0.5 million related to the 2019 Restructuring Plan. To date, we have incurred restructuring charges from continuing operations of $2.4 million related to the 2019 Restructuring Plan. These expenses consist entirely of severance and other employee-related costs.





Depreciation Expense


Depreciation expense from continuing operations increased $0.7 million for the three months ended March 31, 2021 compared to the same period in 2020, primarily due to an increase in the amount of depreciable computer software.





Interest Expense


Interest expense from continuing operations did not change materially from the three months ended March 31, 2020 to the three months ended March 31, 2021.





                                       31

--------------------------------------------------------------------------------






Other (Income) Expense, Net


Other (income) expense, net increased $1.1 million for the three months ended March 31, 2021 compared to the same period in 2020 due to mark-to-market adjustments on certain interest rate swap agreements that, effective in the fourth quarter of 2020, no longer qualify for hedge accounting treatment ("de-designated swaps"). Changes in fair value of the de-designated swaps are required to be recognized each period in current earnings.





Income Tax Expense


See Note 6 of the notes to consolidated financial statements in this report for a discussion of income tax expense from continuing operations.

Liquidity and Capital Resources





Overview


As of March 31, 2021, outstanding debt under the Credit Agreement was $405.2 million, which represented $432.7 million of principal on the Term Loans less deferred loan costs and original issue discount, and we had $52.4 million of cash and cash equivalents.

As of March 31, 2021, we had working capital of $32.8 million. While the COVID-19 pandemic has created significant uncertainty as to general economic and market conditions for the remainder of 2021 and beyond, as of the date of this report, we believe our cash on hand, expected cash flows from operations, and anticipated available credit under the Credit Agreement will be sufficient to fund our operations, principal and interest payments, and capital expenditures for the next 12 months. We cannot assure you that we will be able to secure additional financing if needed and, if such funds are available, whether the terms or conditions will be favorable to us. With the uncertainty surrounding COVID-19, our ability to engage in financing transactions may be constrained by (i) volatile or tight economic, capital, credit and/or financial market conditions, (ii) moderated investor and/or lender interest or capacity, (iii) restrictions under our Credit Agreement, and/or (iv) our liquidity, leverage and net worth, and we can provide no assurance as to successfully completing, the costs of, or the operational limitations arising from, any one or series of such transactions. As of March 31, 2021, availability under the Revolving Credit Facility totaled $124.5 million as calculated under the most restrictive covenant.





Credit Facility

In connection with the consummation of the acquisition of Nutrisystem, on March 8, 2019, we entered into the Credit Agreement. The Credit Agreement provides us with (i) a $350.0 million Term Loan A, (ii) an $830.0 million Term Loan B, (iii) a $125.0 million revolving credit facility that includes a $35.0 million sublimit for swingline loans and a $50.0 million sublimit for letters of credit, and (iv) uncommitted incremental accordion facilities in an aggregate amount at any date equal to the greater of $125.0 million or 50% of our consolidated EBITDA for the then-preceding four fiscal quarters, plus additional amounts based on, among other things, satisfaction of certain financial ratio requirements.

We are required to repay Term Loan A loans in consecutive quarterly installments, each in the amount of 2.50% of the aggregate initial amount of such loans, payable beginning on June 30, 2019 and on the last day of each succeeding quarter thereafter until maturity on March 8, 2024, at which time the entire outstanding principal balance of such loans is due and payable in full.

We are required to repay Term Loan B loans in consecutive quarterly installments, each in the amount of 0.75% of the aggregate initial amount of such loans, payable beginning on June 30, 2019 and on the last day of each succeeding quarter thereafter until maturity on March 8, 2026, at which time the entire outstanding principal balance of such loans is due and payable in full.

We are permitted to make voluntary prepayments of borrowings under the Term Loans at any time without penalty. From March 8, 2019 through March 31, 2021, we made voluntary prepayments of $228.3 million on the Term Loans, which prepaid all scheduled quarterly Term Loan A installments due through September 30, 2022 and all scheduled quarterly Term Loan B installments due through June 30, 2023, excluding any Excess Cash Flow



                                       32

--------------------------------------------------------------------------------

Payments that may be required, as described below. In addition, in December 2020 we used the significant majority of the net proceeds from the divestiture of Nutrisystem to pay $519.0 million of principal on the Term Loans, which was applied to the amount due and payable at maturity.

We are required to repay in full any outstanding swingline loans and revolving loans under the Revolving Credit Facility on March 8, 2024. In addition, the Credit Agreement contains provisions that, beginning with fiscal 2019, may require annual excess cash flow (as defined in the Credit Agreement and generally designed to equal cash generated by our business in excess of cash used in the business) to be applied towards the Term Loans. We are required to make prepayments on the Term Loans equal to our excess cash flow for a given fiscal year multiplied by the following excess cash flow percentages (such resulting payment an "Excess Cash Flow Payment") based on our Net Leverage Ratio (as defined in the Credit Agreement) on the last day of such fiscal year: (a) 75% if the Net Leverage Ratio is greater than 3.75:1, (b) 50% if the Net Leverage Ratio is equal to or less than 3.75:1 but greater than 3.25:1 (c) 25% if the Net Leverage Ratio is equal to or less than 3.25:1 but greater than 2.75:1, and (d) 0% if the Net Leverage Ratio is equal to or less than 2.75:1. Any such potential mandatory prepayments are reduced by voluntary prepayments. We were not required to make an Excess Cash Flow Payment for fiscal 2020.

The Credit Agreement contains a financial covenant that requires us to maintain maximum ratios or levels of consolidated total net debt to consolidated adjusted EBITDA, calculated as provided in the Credit Agreement (the "Net Leverage Ratio"), of 5.25:1.00 for all test dates occurring on or after December 31, 2020 but prior to December 31, 2021 and 4.75:1.00 for all test dates occurring on or after December 31, 2021. As of March 31, 2021, we were in compliance with all of the covenant requirements of the Credit Agreement, and our Net Leverage Ratio was equal to 2.11.

Based on our current assumptions with respect to the COVID-19 pandemic, including, among other things, the outstanding principal on the term loans under our Credit Agreement and the average monthly total participation levels of our members at our fitness partner locations, we currently believe we will be in compliance with the Net Leverage Ratio covenant over the next 12 months. We will continue to monitor our projected ability to comply with all covenants under the Credit Agreement, including the Net Leverage Ratio.

Cash Flows Provided by Operating Activities

Operating activities during the three months ended March 31, 2021 provided cash of $22.6 million compared to $47.0 million during the three months ended March 31, 2020. The decrease is primarily due to (i) reduced cash flows from operating activities from Nutrisystem, which we sold in December 2020, and (ii) reduced cash collections on accounts receivable. These decreases were partially offset by lower interest payments and the receipt of tax refunds in the first quarter of 2021.

Cash Flows Used in Investing Activities

Investing activities during the three months ended March 31, 2021 used $3.2 million in cash, compared to $4.9 million during the three months ended March 31, 2020. This change is primarily due to a decrease in capital expenditures, partially offset by settlement payments on non-designated derivatives.

Cash Flows Provided by Financing Activities

Financing activities during the three months ended March 31, 2021 used $67.4 million of cash, compared to cash provided of $38.4 million during the three months ended March 31, 2020. This decrease is primarily due to voluntary prepayments under the Credit Agreement of $63.6 million during the first quarter of 2021, compared to net borrowings of $37.3 million for the same period in 2020.

Recent Relevant Accounting Standards

See Note 2 of the notes to consolidated financial statements included in this report for discussion of recent relevant accounting standards.





                                       33

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses